Study of CM313(SC) Injection in Subjects With Platelet Transfusion Refractoriness

Clinical trial NCT06792019 · RECRUITING

Trial details

NCT number: NCT06792019
Sponsor: Keymed Biosciences Co.Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Platelet Transfusion Refractoriness

Start date: 2025-03-25
Primary completion: 2027-11-16
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.